Triptolide decreases podocytes permeability by regulating TET2-mediated hydroxymethylation of ZO-1
Experimental Biology and Medicine · 2024
DOI: 10.3389/ebm.2024.10051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2024. Verfasst von Yue-Wen Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Dioxygenases, Diterpenes, Podocytes, Zonula Occludens-1 Protein. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Scientific Research Foundation of Zhejiang Province, China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Podocyte injury or dysfunction can lead to proteinuria and glomerulosclerosis. Zonula occludens 1 (ZO-1) is a tight junction protein which connects slit diaphragm (SD) proteins to the actin cytoskeleton. Previous studies have shown that the expression of ZO-1 is decreased in chronic kidney disease (CKD). Thus, elucidation of the regulation mechanism of ZO-1 has considerable clinical importance. Triptolide (TP) has been reported to exert a strong antiproteinuric effect by inhibiting podocyte epithelial mesenchymal transition (EMT) and inflammatory response. However, the underlying mechanisms are still unclear. We found that TP upregulates ZO-1 expression and increases the fluorescence intensity of ZO-1 in a puromycin aminonucleoside (PAN)-induced podocyte injury model. Permeablity assay showed TP decreases podocyte permeability in PAN-treated podocyte. TP also upregulates the DNA demethylase TET2. Our results showed that treatment with the DNA methyltransferase inhibitors 5-azacytidine (5-AzaC) and RG108 significantly increased ZO-1 expression in PAN-treated podocytes. Methylated DNA immunoprecipitation (MeDIP) and hydroxymethylated DNA immunoprecipitation (hMeDIP) results showed that TP regulates the methylation status of the ZO-1 promoter. Knockdown of TET2 decreased ZO-1 expression and increased methylation of its promoter, resulting in the increase of podocyte permeability. Altogether, these results indicate that TP upregulates the expression of ZO-1 and decreases podocyte permeability through TET2-mediated 5 mC demethylation. These findings suggest that TP may alleviate podocyte permeability through TET2-mediated hydroxymethylation of ZO-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
- Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, China.
Förderung
- Medical Scientific Research Foundation of Zhejiang Province, China
- National Natural Science Foundation of China
Zitieren
APA
Tang, Y. W., Jiang, M. Y., Cao, J. W., & Wan, F. (2024). Triptolide decreases podocytes permeability by regulating TET2-mediated hydroxymethylation of ZO-1. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2024.10051
Vancouver
Tang YW, Jiang MY, Cao JW, Wan F. Triptolide decreases podocytes permeability by regulating TET2-mediated hydroxymethylation of ZO-1. Experimental Biology and Medicine. 2024. doi:10.3389/ebm.2024.10051
BibTeX
@article{Tang2024,
author = {Tang, Yue-Wen and Jiang, Meng-Ya and Cao, Jia-Wei and Wan, Feng},
title = {Triptolide decreases podocytes permeability by regulating TET2-mediated hydroxymethylation of ZO-1},
journal = {Experimental Biology and Medicine},
year = {2024},
doi = {10.3389/ebm.2024.10051}
}
EUVIMED